Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.

Biotechnology

Health Care

Hopstem

Hopstem's headquarters in Hangzhou, China

Jing Fan

Shuning Zhang

Anxin Wang

John Xu

Ted M. Dawson

Yutian Wang

Frank Li

Valina L. Dawson

The Advisory Team at Hopstem provides strategic guidance and expertise in the development and commercialization of innovative therapies using human iPSCs and ESCs. Comprised of seasoned advisors and leadership, the team collaborates to enhance research initiatives, inform business strategies, and establish partnerships that drive the company’s vision in cell banking and cell engineering.

Advisory Team

The Leadership Team at Hopstem drives the company’s strategic vision and operational execution in the pharmaceutical sector. Comprising the CEO and Chief Business Officer, the team focuses on fostering innovation in human iPSCs/ESCs neural differentiation, advancing cell banking solutions, and enhancing cell engineering initiatives to ensure market competitiveness and sustainable growth.

Leadership Team

The Research and Development team at Hopstem focuses on pioneering innovative methods for differentiating human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) into neural cells. They conduct cutting-edge research to advance cell banking and engineering techniques, ensuring the development of effective treatments while collaborating on regulatory compliance for new therapies.

Hopstem

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Research and Development

Offices

Hopstem

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Research and Development

Offices

Related companies